Nanoviricides (NNVC) Cash from Investing Activities (QoQ) (2010 - 2025)
Nanoviricides (NNVC) Cash from Investing Activities (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.00% |
| Sep 30, 2025 | -726.64% |
| Sep 30, 2024 | 52.36% |
| Jun 30, 2024 | -119.94% |
| Mar 31, 2024 | -715.35% |
| Dec 31, 2023 | 33.98% |
| Sep 30, 2023 | -223.11% |
| Jun 30, 2015 | -259.64% |
| Mar 31, 2015 | 115.77% |
| Dec 31, 2014 | -744.57% |
| Sep 30, 2014 | 8.22% |
| Jun 30, 2014 | 51.37% |
| Mar 31, 2014 | -1,400.37% |
| Dec 31, 2013 | 97.43% |
| Sep 30, 2013 | -4,942.26% |
| Jun 30, 2013 | 93.51% |
| Jun 30, 2012 | 99.99% |
| Mar 31, 2012 | 38.61% |
| Dec 31, 2011 | 37.23% |
| Sep 30, 2011 | -24.95% |